Ra Pharmaceuticals, Inc.
SEC CIK 1481512 · RARX · last insider filing 2020-04-03
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| RA Capital Healthcare Fund LP | Director | filed 2016 - 2020 |
| Mathers Edward T | Director | filed 2016 - 2020 |
| RA Capital Management, LLC | Director | filed 2016 - 2020 |
| Kolchinsky Peter | Director | filed 2016 - 2020 |
| Pearson Timothy R | Director | filed 2016 - 2020 |
| Shah Rajeev M. | Director | filed 2016 - 2020 |
| Cumbo Alexander | Director | filed 2018 - 2020 |
| Treco Douglas A | Director · President and CEO | filed 2016 - 2020 |
| Heft Robert | Director | filed 2016 - 2020 |
| Brennan Aoife | Director | filed 2018 - 2020 |
| Bisgaard Peter | Director | filed 2016 - 2018 |
| Lettmann Jason | Director | filed 2016 - 2017 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Lubner David Charles | VP Operations & CFO | filed 2016 - 2020 |
| Farzaneh-Far Ramin | Chief Medical Officer | filed 2016 - 2020 |
| Read Simon | Chief Scientific Officer | filed 2016 - 2020 |
| King John C | Chief Commercial Officer | filed 2018 - 2020 |
| Ricardo Alonso | See Remarks | filed 2019 - 2020 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.